| NCT Number | NCT07360275 |
| Lead Sponsor | Vincentage Pharma Co., Ltd |
| Conditions | Hypertension |
| Enrollment | 160 participants |
| Start Date | 2026-03-01 |
| Primary Completion | 2026-10-20 (estimated) |
| Study Completion | 2026-12-20 (estimated) |
| Updated on ClinicalTrials.gov | 2026-01-22 |